Switchback from Biosimilar to Biologic Rare Among Veteran Patients
Very few patients switch off a biosimilar due to adverse effects, according to a new study.
Source: hcplive.com
Stay updated with breaking news from Kellym Bryan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Very few patients switch off a biosimilar due to adverse effects, according to a new study.